ACHC - CIK 0001520697
The table below shows Acadia Healthcare Company, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $131.90M | $129.69M | $462.34M | $380.57M | $374.48M | $658.81M |
| Capital expenditure | $571.81M | $690.38M | $424.13M | $296.15M | $244.81M | $224.96M |
| Investing cash flow | -$556.21M | -$736.48M | -$397.22M | -$305.83M | $1.01B | -$281.84M |
| Dividends paid | - | - | - | - | - |
Acadia Healthcare Company, Inc. reported operating cash flow of $131.90M for fiscal year 2025. That is up 1.7% from $129.69M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $361.48M (FY 2016) to $131.90M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $50.03M | - | - | - | - | - |
| Financing cash flow | $481.25M | $583.02M | -$62.70M | -$110.90M | -$1.64B | -$51.50M |